Bluejay Diagnostics Stock to Reverse Split on Thursday, June 20th (NASDAQ:BJDX)

Bluejay Diagnostics, Inc. (NASDAQ:BJDXFree Report)’s stock is set to reverse split before the market opens on Thursday, June 20th. The 1-8 reverse split was announced on Thursday, June 20th. The number of shares owned by shareholders will be adjusted after the market closes on Thursday, June 20th.

Bluejay Diagnostics Stock Performance

Shares of BJDX stock opened at $0.41 on Tuesday. Bluejay Diagnostics has a fifty-two week low of $0.34 and a fifty-two week high of $13.98. The stock has a 50 day moving average price of $0.54 and a two-hundred day moving average price of $1.04. The company has a market capitalization of $1.09 million, a P/E ratio of -0.05 and a beta of 1.06.

Bluejay Diagnostics (NASDAQ:BJDXGet Free Report) last posted its earnings results on Thursday, March 28th. The company reported ($1.78) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.68) by ($1.10).

Hedge Funds Weigh In On Bluejay Diagnostics

An institutional investor recently bought a new position in Bluejay Diagnostics stock. Armistice Capital LLC bought a new stake in shares of Bluejay Diagnostics, Inc. (NASDAQ:BJDXFree Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 24,230 shares of the company’s stock, valued at approximately $30,000. Armistice Capital LLC owned 1.95% of Bluejay Diagnostics as of its most recent filing with the Securities and Exchange Commission (SEC). Institutional investors own 18.47% of the company’s stock.

Bluejay Diagnostics Company Profile

(Get Free Report)

Bluejay Diagnostics, Inc, a medical diagnostic company, develops rapid test for the monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components.

Further Reading

Receive News & Ratings for Bluejay Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bluejay Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.